NCT06100952 - Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age with Keratoconus | Biotech Hunter

Enrollment

400

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions

Keratoconus

Interventions

COMBINATION_PRODUCT

Riboflavin and Sodium Iodide solution and Ultraviolet-A treatment

"Drug: Ribostat riboflavin and sodium iodide ophthalmic solution~Device: UV-3000 ultraviolet A light source"

COMBINATION_PRODUCT

Placebo and sham treatment

"Drug: placebo ophthalmic solution~Device: UV-3000 light source"

Trial Locations (12)

Virginia Eye Consultants, Norfolk

Providence Eye and Laser Specialists, Charlotte

VRF Eye Specialty Group, Memphis

Chicago Cornea Consultants, Highland Park

Truhlsen Eye Institute, Omaha

Dell Laser Consultants, Austin

University of Colorado, Aurora

Hoopes Vision, Draper

Schwartz Laser Eye Center, Scottsdale

Catalina Eye Center, Tucson

Inland Eye Specialists, Murrieta

Claris Vision LLC Eye Health Vision Centers - Dartmouth, North Dartmouth